Osteoporosis - PowerPoint PPT Presentation

1 / 29
About This Presentation
Title:

Osteoporosis

Description:

Osteoporosis UBC Internal Medicine Program Dr. Mark Fok Dr. Maria Ashley Minor Risk Factors Rheumatoid arthritis Hyperthyroidism Prolonged anticonvulsants Prolonged ... – PowerPoint PPT presentation

Number of Views:126
Avg rating:3.0/5.0
Slides: 30
Provided by: Providenc6
Category:

less

Transcript and Presenter's Notes

Title: Osteoporosis


1
Osteoporosis
  • UBC Internal Medicine Program
  • Dr. Mark Fok
  • Dr. Maria Ashley

2
Definition
  • Osteoporosis and osteopenia are skeletal
    disorders characterized by low bone mass and
    microarchitectural fragility.

3
Bone remodelling
4
Incidence
  • 1.4 million Canadians affected
  • 1 in 4 women over age 50 and 1 in 8 men over age
    50
  • Estimated cost of 1.9 billion to treat
    osteoporosis and fractures in Canada
  • 70 of hip fractures are osteoporosis related
  • www.osteoporosis.ca

5
What else do you want to know?
  • Major Risk Factors for Osteoporosis
  • Age gt65
  • Vertebral compression
  • Family hx of osteoporotic
  • gt5 months glucocorticoid tx
  • Malabsorbtion syndrome
  • 1 hyperparathyroidism
  • Osteopenia on XR
  • Hypogonadism
  • Early menopause (before 45)

6
  • Minor Risk Factors
  • Rheumatoid arthritis
  • Hyperthyroidism
  • Prolonged anticonvulsants
  • Prolonged heparin use
  • Body weight lt57kg
  • Low calcium intake
  • Excess caffeine (gt4 cups/day)
  • Excess alcohol (gt2 drinks/day)
  • Smoker

7
Risk for Fracture
  • Low Bone Mineral Density
  • Prior fragility fracture
  • Long term (gt3 months) glucocorticoids
  • Increasing age
  • Family history of osteoporotic fracture

8
Signs and Symptoms of Osteoporosis
  • Self reported height loss gt3cm
  • Weight lt51kg
  • Kyphosis - Self reported hump back
  • Grip strength lt40lb
  • Tooth count lt20

9
Diagnosis of Osteoporosis
  • Assessment bone microarchitecture bone biopsy
  • Clinical fracture in the right context
  • Gold standard

10
Bone Mineral Density Assessment
  • Dual-Energy Xray Absorptiometry (DXA)
  • Strong correlation between mechanical bone
    strength DXA measurement of BMD
  • Strong relationship between fracture risk and BMD
    measurement

Lotz JC et al. J Biomech Eng 1991 Marshall D et
al. BMJ 1996
11
DXA
  • Xray tube generates photon beams at two energy
    levels
  • Difference in attenuation ? BMD determination
  • For comparison, must use same machine

12
Interpreting a DXA Scan ?

13
Interpreting the DXA
  • T-score
  • Standard deviation between a pts BMD and that of
    a young adult reference population
  • Z-score
  • Standard deviation between a pts BMD and that of
    an age matched population

14
Interpreting the DXA WHO criteria
Normal - 1 lt T score
Low Bone Mass (osteopenia) - 2. 5 lt T score lt - 1
Osteoporosis T score lt - 2.5
Severe osteoporosis T score lt - 2.5 fragility fracture
15
DXA scan hip / L-spine
16
Treatment of Osteoporosis
  • Non-drug options
  • Drug options

17
Weight bearing exercises
18
  • Exercises that utilize your own body weight
    include activities like these, but also include
    simple activities like walking.

19
Calcium rich foods
20
Over the counter vitamins
  • 1200-1500 mg elemental calcium per day
  • 800 IU vitamin D per day

21
Drugs Bisphosphonates
  • Alendronate
  • Risedronate
  • Etidronate

22
Dosing
  • Once weekly dosing (70 mg q week) as effective as
    daily dosing of alendronate with similar side
    effect profile

Rizzoli et al. J Bone Miner Res 2002
23
Risedronate
  • Similar efficacy
  • Comparable to Alendronate

Rosen et al. J Bone Miner. Res. 2005
24
Selective Estrogen Receptor Modulators
  • Raloxifene
  • Tamoxifen
  • Bind with high affinity to Estrogen Receptor and
    possess tissue selective agonist / antagonist
    properties ? bone specific estrogen like action

25
Bone Forming (Anabolic) Medications
  • Parathyroid Hormone Teriparatide (brand name -
    Forteo).
  • Teriparatide, a type of parathyroid hormone, is
    approved for the treatment of osteoporosis in
    postmenopausal women and in men who have very low
    BMD or are at high risk for a fracture.

26
Estrogen therapy
  • Fallen out of favor for treatment of osteoporosis
    since WHI study
  • Increased risk of CHD, VT, breast CA
  • Should not be used first line, except for in
    women using it for other indications

27
(No Transcript)
28
  • Quick quiz 1.Are you over 65? 2.Has either of
    your parents broken a bone after a minor bump or
    fall? 3.Have you broken a bone after a minor
    bump or fall? 4.Have you taken glucocorticoid
    pills (cortisone, prednisone, etc.) for more than
    three months? 5.Have you lost more than 4 cm
    (about 1 1/2 inches) in height since age 25 (or 6
    cm if you are over 60)? 6.Do you have a tendency
    to fall? 7.Do you have primary
    hyperparathyroidism? 8.Do you have a medical
    condition (such as celiac disease or Crohn's
    disease) that inhibits absorption of nutrients?
    9.Has a recent x-ray suggested you have low bone
    density (osteopenia)?
  • For Women10.Did you undergo menopause before age
    45? 11.Have your periods stopped for several
    months or more (other than for pregnancy or
    menopause)?
  • For Men12.Have you ever suffered from impotence,
    lack of libido or other symptoms related to low
    levels of testosterone?
  • If you're over 50 and have answered yes to any of
    these questions, Osteoporosis Canada recommends
    that you talk to your doctor about having a bone
    mineral density (BMD) test.

29
Thank you
Write a Comment
User Comments (0)
About PowerShow.com